Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Nivolumab shows early promise in Hodgkin lymphoma

Dr Phillippe Armand - Dana-Farber Cancer Institute, Boston, USA
Nivolumab shows early promise in Hodgkin lymphoma ( Dr Phillippe Armand - Dana-Farber Cancer Institute, Boston, USA )
7 Dec 2014

Blinatumomab demonstrates significant clinical activity in residual ALL

Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany
Blinatumomab demonstrates significant clinical activity in residual ALL ( Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany )
7 Dec 2014

New immunotherapy compound effective, safe in ALL patients with minimal residual disease

Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany
New immunotherapy compound effective, safe in ALL patients with minimal residual disease ( Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany )
7 Dec 2014

T cell therapy leading to prolonged remission for children with aggressive leukaemia

Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA
T cell therapy leading to prolonged remission for children with aggressive leukaemia ( Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA )
7 Dec 2014

Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014

ASH 2014: Expert discussion on the latest in AML

Prof Alan Burnett and Prof Sergio Amadori
ASH 2014: Expert discussion on the latest in AML ( Prof Alan Burnett and Prof Sergio Amadori )
7 Dec 2014

Pembrolizumab may bring hope for patients with Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Pembrolizumab may bring hope for patients with Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014

Immunology highlights from ASH 2014

Dr Catherine Bollard - George Washington University, Washington, USA
Immunology highlights from ASH 2014 ( Dr Catherine Bollard - George Washington University, Washington, USA )
7 Dec 2014

Comment: T cell therapy for children with aggressive leukaemia

Dr Catherine Bollard - George Washington University, Washington, USA
Comment: T cell therapy for children with aggressive leukaemia ( Dr Catherine Bollard - George Washington University, Washington, USA )
7 Dec 2014

Comment: Blinatumomab for acute lymphocytic leukaemia

Dr Catherine Bollard - George Washington University, Washington, USA
Comment: Blinatumomab for acute lymphocytic leukaemia ( Dr Catherine Bollard - George Washington University, Washington, USA )
7 Dec 2014

Comment: New PD-1 checkpoint inhibitors for treating Hodgkin lymphoma

Dr Catherine Bollard - George Washington University, Washington, USA
Comment: New PD-1 checkpoint inhibitors for treating Hodgkin lymphoma ( Dr Catherine Bollard - George Washington University, Washington, USA )
7 Dec 2014

ASH 2014: Expert discussion on the latest in CLL

Prof John Gribben and Prof Stephan Stilgenbauer
ASH 2014: Expert discussion on the latest in CLL ( Prof John Gribben and Prof Stephan Stilgenbauer )
7 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation